1997
DOI: 10.1016/s0040-4039(97)01234-3
|View full text |Cite
|
Sign up to set email alerts
|

Amphimic acids, novel unsaturated C28 fatty acids as DNA topoisomerase I inhibitors from an Australian sponge Amphimedon sp.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
19
0

Year Published

2002
2002
2014
2014

Publication Types

Select...
6
2

Relationship

0
8

Authors

Journals

citations
Cited by 40 publications
(19 citation statements)
references
References 10 publications
0
19
0
Order By: Relevance
“…Recently, Nemoto et al (10) isolated free demospongic acids as human DNA topoisomerase-I inhibitors from the sponge Amphimedon sp. and characterized them by spectral methods, including nuclear magnetic resonance (NMR) spectroscopy.…”
mentioning
confidence: 99%
“…Recently, Nemoto et al (10) isolated free demospongic acids as human DNA topoisomerase-I inhibitors from the sponge Amphimedon sp. and characterized them by spectral methods, including nuclear magnetic resonance (NMR) spectroscopy.…”
mentioning
confidence: 99%
“…Little is known about biological activities of these longchain unsaturated FA, except the DNA topoisomerase I inhibition of ∆5,9,21-30:3 (9). To the best of our knowledge, this is the first report of a long-chain fatty ester as an elastase inhibitor.…”
Section: Resultsmentioning
confidence: 95%
“…Acid 5,9,21-30:3 was isolated from Amphimedon sp. and described as a DNA topoisomerase I inhibitor (9).…”
mentioning
confidence: 99%
“…[1][2][3][4][5][6][7][8][9] Topoisomerase I is a key enzyme in the breaking and fixing of DNA strands and is involved in making the necessary topological changes to DNA for key cellular processes such as replication, transcription, and recombination. 1 Topoisomerases have also evolved as key cellular targets for the development of effective anticancer drugs.…”
Section: Introductionmentioning
confidence: 99%
“…1 Other interesting topo-I lipid inhibitors include conjugated C 18 and eicosapentaenoic fatty acids, 2,4 very-long chain (C 26 -C 30 ) ∆5,9 fatty acids, 5,6 and phospholipids containing unsaturated fatty acids. 7 While most of the fatty acid topoisomerase-I inhibitory work has been performed with straight-chain fatty acids, there is just one report dealing with the topoisomerase I inhibitory activity of methyl-branched iso and anteiso fatty acids.…”
Section: Introductionmentioning
confidence: 99%